Overview
Streptococcus pneumoniae type 18c capsular polysaccharide antigen is a vaccine that contains highly purified capsular polysaccharides from the invasive pneumococcal type 18c of Streptococcus pneumoniae. It is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
Indication
No indication information available.
Associated Conditions
- Pneumococcal Infection
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
Authorised | 12/9/2009 | ||
Authorised | 3/29/2009 | ||
Authorised | 2/14/2022 |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| APEXXNAR SUSPENSION FOR INJECTION IN SINGLE-DOSE PRE-FILLED SYRINGE 0.5ML | SIN16648P | INJECTION, SUSPENSION | 2.2 μg/0.5ml | 11/30/2022 | |
| Prevenar 13 Suspension For Injection | SIN13824P | INJECTION, SUSPENSION | 2.2mcg | 7/2/2010 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| PREVNAR 13 | 02335204 | Suspension - Intramuscular | 2.2 MCG / 0.5 ML | 3/1/2010 | |
| PREVNAR | 02244081 | Suspension - Intramuscular | 2 MCG / 0.5 ML | 6/20/2001 | |
| PREVNAR 20 | 02527049 | Suspension - Intramuscular | 2.2 MCG / 0.5 ML | 7/8/2022 | |
| VAXNEUVANCE | Merck Canada Inc | 02522403 | Suspension - Intramuscular | 2 MCG / 0.5 ML | 9/2/2022 |
| PNEUMO 23 | 02231259 | Liquid - Subcutaneous
,
Intramuscular | 25 MCG / 0.5 ML | 9/3/1997 | |
| PNEUMOVAX 23 | Merck Canada Inc | 00431648 | Solution - Subcutaneous
,
Intramuscular | 25 MCG / 0.5 ML | 12/31/1978 |
| PNEUMOVAX 23 | Merck Canada Inc | 02436442 | Solution - Subcutaneous
,
Intramuscular | 25 MCG / 0.5 ML | 4/7/2021 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.